“…High encapsulation efficacy has been reported for hydrophilic guest macromolecules such as brain-derived neurotrophic factor (BDNF), ovalbulmin and protein vaccines [11,20,21,22,23,24]. Soluble, peripheral, and integral membrane proteins have been studied in LCPs in relation to in meso protein crystallization, biosensor development involving encapsulated enzymes, and drug-delivery systems [21,22,23,24,25,26,27,28]. LCP-derived nanocarriers are increasingly used in a range of applications employing lipophilic drugs and theranostic agents [14,15,16,17,18,19].…”